• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于开发能提供长效免疫的单次注射疫苗的聚己内酯(PCL)纳米佐剂的制备。

Fabrication of nanoadjuvant with poly-ε-caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity.

作者信息

Prashant Chandravilas Keshvan, Bhat Madhusudan, Srivastava Sandeep Kumar, Saxena Ankit, Kumar Manoj, Singh Amar, Samim Mohammed, Ahmad Farhan Jalees, Dinda Amit Kumar

机构信息

Department of Pathology, All India Institute of Medical Sciences, Jamia Hamdard, New Delhi, India.

Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, Jamia Hamdard, New Delhi, India.

出版信息

Int J Nanomedicine. 2014 Feb 12;9:937-50. doi: 10.2147/IJN.S55892. eCollection 2014.

DOI:10.2147/IJN.S55892
PMID:24611010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3928464/
Abstract

PURPOSE

The aim of the study was to load a model antigen, tetanus toxoid (TT), in poly-ε-caprolactone nanoparticles (PCL NPs) of two size ranges, ie, mean 61.2 nm (small) and 467.6 nm (large), and study its effect on macrophage polarization as well as antigen presentation in human monocyte-derived macrophages in vitro, along with humoral and cell-mediated immune (CMI) response generated in Swiss albino mice following immunization with the TT-loaded NPs.

MATERIALS AND METHODS

PCL NPs were synthesized by solvent evaporation. The antigen-loaded PCL NPs were characterized for size, zeta potential, and protein-release kinetics. Swiss albino mice were immunized with the antigen-loaded PCL NPs. Flow cytometry was used to quantify interferon-γ- and interleukin-4-secreting cluster of differentiation (CD)4(+) and CD8(+) T cells in the spleen, and enzyme-linked immunosorbent assay was used to quantify anti-TT antibody levels in the serum of immunized mice.

RESULTS

Small PCL NPs generated an M1/M2 type polarization of human blood monocyte-derived macrophages and T helper (Th)1/Th2 polarization of autologous CD4(+) T cells. Efficient CD8(+) T-cell responses were also elicited. Large PCL NPs failed to cause any type of macrophage polarization. They did not elicit efficient CD8(+) T-cell responses.

CONCLUSION

TT-loaded small PCL NPs were able to generate persistent and strong CMI and humoral responses against TT 2 months after single injection in mice without booster dose. This biodegradable nanoadjuvant system may help to develop single-shot immunization for prolonged immunity without booster doses. The capability of enhanced CMI response may have high translational potential for immunization against intracellular infection.

摘要

目的

本研究旨在将模型抗原破伤风类毒素(TT)负载于两种尺寸范围的聚ε-己内酯纳米颗粒(PCL NPs)中,即平均粒径为61.2 nm(小)和467.6 nm(大),研究其对人单核细胞衍生巨噬细胞中巨噬细胞极化以及抗原呈递的影响,以及用负载TT的纳米颗粒免疫瑞士白化小鼠后产生的体液免疫和细胞介导免疫(CMI)反应。

材料与方法

通过溶剂蒸发合成PCL NPs。对负载抗原的PCL NPs进行尺寸、zeta电位和蛋白质释放动力学表征。用负载抗原的PCL NPs免疫瑞士白化小鼠。采用流式细胞术定量脾脏中分泌干扰素-γ和白细胞介素-4的分化簇(CD)4(+)和CD8(+) T细胞,并用酶联免疫吸附测定法定量免疫小鼠血清中的抗TT抗体水平。

结果

小尺寸PCL NPs可使人血单核细胞衍生巨噬细胞产生M1/M2型极化,使自体CD4(+) T细胞产生辅助性T细胞(Th)1/Th2极化。还可有效引发CD8(+) T细胞反应。大尺寸PCL NPs未能引起任何类型的巨噬细胞极化。它们未引发有效的CD8(+) T细胞反应。

结论

负载TT的小尺寸PCL NPs在小鼠单次注射后2个月无需加强剂量就能产生针对TT的持续而强烈的CMI和体液反应。这种可生物降解的纳米佐剂系统可能有助于开发无需加强剂量的单次注射长效免疫方法。增强CMI反应的能力对于针对细胞内感染的免疫接种可能具有很高的转化潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/f11956946333/ijn-9-937Fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/6730452e5587/ijn-9-937Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/34e5928d50cd/ijn-9-937Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/9df97a45baa7/ijn-9-937Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/2bb359e6e554/ijn-9-937Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/b68fe9fdd194/ijn-9-937Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/92ea9a2bcf30/ijn-9-937Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/cf2d22d85887/ijn-9-937Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/53d1e23cc3ab/ijn-9-937Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/d8bc2cc7f1af/ijn-9-937Fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/f11956946333/ijn-9-937Fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/6730452e5587/ijn-9-937Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/34e5928d50cd/ijn-9-937Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/9df97a45baa7/ijn-9-937Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/2bb359e6e554/ijn-9-937Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/b68fe9fdd194/ijn-9-937Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/92ea9a2bcf30/ijn-9-937Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/cf2d22d85887/ijn-9-937Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/53d1e23cc3ab/ijn-9-937Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/d8bc2cc7f1af/ijn-9-937Fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0ee/3928464/f11956946333/ijn-9-937Fig10.jpg

相似文献

1
Fabrication of nanoadjuvant with poly-ε-caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity.用于开发能提供长效免疫的单次注射疫苗的聚己内酯(PCL)纳米佐剂的制备。
Int J Nanomedicine. 2014 Feb 12;9:937-50. doi: 10.2147/IJN.S55892. eCollection 2014.
2
Adjuvant Activity of Poly-ε-caprolactone/Chitosan Nanoparticles Characterized by Mast Cell Activation and IFN-γ and IL-17 Production.聚己内酯/壳聚糖纳米粒子通过肥大细胞活化和 IFN-γ 和 IL-17 产生的佐剂活性。
Mol Pharm. 2018 Jan 2;15(1):72-82. doi: 10.1021/acs.molpharmaceut.7b00730. Epub 2017 Dec 7.
3
Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.壳聚糖包被聚己内酯纳米粒系统的研制及其对流感的有效免疫作用。
Vaccine. 2011 Nov 8;29(48):9026-37. doi: 10.1016/j.vaccine.2011.09.033. Epub 2011 Sep 20.
4
In vivo efficacy and toxicity evaluation of polycaprolactone nanoparticles and aluminum based admixture formulation as vaccine delivery system.聚己内酯纳米颗粒和铝基混合制剂作为疫苗递送系统的体内疗效和毒性评估
Vaccine. 2015 Oct 13;33(42):5623-5632. doi: 10.1016/j.vaccine.2015.08.076. Epub 2015 Sep 4.
5
Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid.与包裹破伤风类毒素的壳聚糖纳米球混合的交联葡聚糖微球的免疫佐剂潜力。
Pharm Biol. 2017 Dec;55(1):212-217. doi: 10.1080/13880209.2016.1257032.
6
Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.通过使用不同的免疫方案和佐剂,可提高包裹破伤风类毒素的可生物降解聚合物颗粒的免疫反应。
Int J Pharm. 2002 Oct 1;245(1-2):109-21. doi: 10.1016/s0378-5173(02)00342-3.
7
Immune response elicited by an intranasally delivered HBsAg low-dose adsorbed to poly-ε-caprolactone based nanoparticles.经鼻递送的吸附于聚ε-己内酯基纳米颗粒上的低剂量乙肝表面抗原引发的免疫反应。
Int J Pharm. 2016 May 17;504(1-2):59-69. doi: 10.1016/j.ijpharm.2016.03.013. Epub 2016 Mar 11.
8
Design, optimization and evaluation of poly-ε-caprolactone (PCL) based polymeric nanoparticles for oral delivery of lopinavir.基于聚ε-己内酯(PCL)的聚合物纳米粒用于洛匹那韦口服给药的设计、优化与评价
Drug Dev Ind Pharm. 2015 Jan;41(1):131-40. doi: 10.3109/03639045.2013.850710. Epub 2013 Nov 4.
9
Oral vaccine models: multiple delivery systems employing tetanus toxoid.口服疫苗模型:采用破伤风类毒素的多种递送系统。
Ann N Y Acad Sci. 1994 Aug 15;730:217-34. doi: 10.1111/j.1749-6632.1994.tb44251.x.
10
PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses.PLGA 纳米颗粒介导的肿瘤抗原肽递呈引发有效的免疫应答。
Int J Nanomedicine. 2012;7:1475-87. doi: 10.2147/IJN.S29506. Epub 2012 Mar 15.

引用本文的文献

1
Beyond Needles: Immunomodulatory Hydrogel-Guided Vaccine Delivery Systems.超越针头:免疫调节水凝胶引导的疫苗递送系统
Gels. 2024 Dec 26;11(1):7. doi: 10.3390/gels11010007.
2
Biodegradable polymers for modern vaccine development.用于现代疫苗开发的可生物降解聚合物。
J Ind Eng Chem. 2019 Sep 25;77:12-24. doi: 10.1016/j.jiec.2019.04.044. Epub 2019 Apr 28.
3
Nanomaterials for cancer immunotherapy.用于癌症免疫疗法的纳米材料。

本文引用的文献

1
Characterisation of local immune responses induced by a novel nano-particle based carrier-adjuvant in sheep.新型纳米颗粒载体佐剂在绵羊体内诱导的局部免疫反应的表征
Vet Immunol Immunopathol. 2013 Sep 1;155(1-2):21-9. doi: 10.1016/j.vetimm.2013.05.015. Epub 2013 Jun 6.
2
Antigen-loaded nanocarriers enhance the migration of stimulated Langerhans cells to draining lymph nodes and induce effective transcutaneous immunization.载抗原的纳米载体增强了受刺激的朗格汉斯细胞向引流淋巴结的迁移,并诱导有效的经皮免疫。
Nanomedicine. 2014 Jan;10(1):215-23. doi: 10.1016/j.nano.2013.06.007. Epub 2013 Jun 21.
3
A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge.
Biomaterials. 2017 Dec;148:16-30. doi: 10.1016/j.biomaterials.2017.09.017. Epub 2017 Sep 17.
4
Non-invasive administration of biodegradable nano-carrier vaccines.可生物降解纳米载体疫苗的非侵入性给药。
Am J Transl Res. 2017 Jan 15;9(1):15-35. eCollection 2017.
一种单剂量 PLGA 包封保护性抗原结构域 4 纳米制剂可保护小鼠免受炭疽芽孢杆菌孢子的攻击。
PLoS One. 2013 Apr 29;8(4):e61885. doi: 10.1371/journal.pone.0061885. Print 2013.
4
Mesoporous silica nanoparticles act as a self-adjuvant for ovalbumin model antigen in mice.介孔硅纳米颗粒在小鼠中作为卵清蛋白模型抗原的内源性佐剂。
Small. 2013 Sep 23;9(18):3138-46. doi: 10.1002/smll.201300012. Epub 2013 Apr 26.
5
pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.pH 响应性纳米颗粒疫苗用于双重递呈抗原和免疫刺激性寡核苷酸。
ACS Nano. 2013 May 28;7(5):3912-25. doi: 10.1021/nn305466z. Epub 2013 Apr 30.
6
Single low-dose un-adjuvanted HBsAg nanoparticle vaccine elicits robust, durable immunity.单剂低剂量未佐剂 HBsAg 纳米颗粒疫苗可诱导强大、持久的免疫应答。
Nanomedicine. 2013 Oct;9(7):923-34. doi: 10.1016/j.nano.2013.03.008. Epub 2013 Mar 27.
7
Biomimetic antigenic nanoparticles elicit controlled protective immune response to influenza.仿生抗原纳米颗粒引发针对流感的可控保护性免疫应答。
ACS Nano. 2013 Apr 23;7(4):3036-44. doi: 10.1021/nn4006544. Epub 2013 Apr 10.
8
Conjunctival vaccination against Brucella ovis in mice with mannosylated nanoparticles.用甘露糖化纳米粒对感染羊种布鲁氏菌的小鼠进行结膜接种。
J Control Release. 2012 Sep 28;162(3):553-60. doi: 10.1016/j.jconrel.2012.07.030. Epub 2012 Jul 28.
9
Enhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: effect of silica architecture on immunological properties.多孔硅纳米粒子作为口服疫苗佐剂增强黏膜和全身免疫应答:硅石结构对免疫特性的影响。
Int J Pharm. 2012 Oct 15;436(1-2):351-8. doi: 10.1016/j.ijpharm.2012.06.028. Epub 2012 Jun 18.
10
PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses.PLGA 纳米颗粒介导的肿瘤抗原肽递呈引发有效的免疫应答。
Int J Nanomedicine. 2012;7:1475-87. doi: 10.2147/IJN.S29506. Epub 2012 Mar 15.